Showing 15,861 - 15,880 results of 120,818 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (mean decrease)) ))', query time: 1.58s Refine Results
  1. 15861

    Solvent-Induced Change of Electronic Spectra and Magnetic Susceptibility of Co<sup>II</sup> Coordination Polymer with 2,4,6-Tris(4-pyridyl)-1,3,5-triazine by Ruslan A. Polunin (1593139)

    Published 2015
    “…Formation of <b>2</b> from <b>1</b> was accompanied by change of color of sample from orange to brown and more than 2-fold decrease of molar magnetic susceptibility (χ<sub>M</sub>) in the temperature range from 2 to 300 K. …”
  2. 15862
  3. 15863
  4. 15864
  5. 15865

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…Here, we proposed the concept of “nonbioavailable substructures”, referring to substructures that are unfavorable to bioavailability. A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  6. 15866

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…Here, we proposed the concept of “nonbioavailable substructures”, referring to substructures that are unfavorable to bioavailability. A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  7. 15867

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…Here, we proposed the concept of “nonbioavailable substructures”, referring to substructures that are unfavorable to bioavailability. A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  8. 15868

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…Here, we proposed the concept of “nonbioavailable substructures”, referring to substructures that are unfavorable to bioavailability. A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  9. 15869

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…Here, we proposed the concept of “nonbioavailable substructures”, referring to substructures that are unfavorable to bioavailability. A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  10. 15870

    Mean and variance of <i>r</i><sup>2</sup> between rare and common sites as a function of rate of recombination. by Samuel P. Dickson (242256)

    Published 2013
    “…Although the mean is a nonincreasing function of recombination, the variance increases then decreases, which shows why the maximum <i>r</i><sup>2</sup> between rare and common variants can increase with low amounts of recombination in a region.…”
  11. 15871
  12. 15872
  13. 15873

    Investigating the shared genetics of non-syndromic cleft lip/palate and facial morphology by Laurence J. Howe (5579186)

    Published 2018
    “…Where evidence was found of genetic overlap, we used bidirectional Mendelian randomization (MR) to test the hypothesis that genetic liability to nsCL/P is causally related to implicated facial phenotypes. Across 5,804 individuals of European ancestry from two studies, we found strong evidence, using PRS, of genetic overlap between nsCL/P and philtrum width; a 1 S.D. increase in nsCL/P PRS was associated with a 0.10 mm decrease in philtrum width (95% C.I. 0.054, 0.146; P = 2x10<sup>-5</sup>). …”
  14. 15874
  15. 15875
  16. 15876
  17. 15877
  18. 15878

    VEGF overexpression in OU culture increased OU size and altered stem/progenitor cell gene expression. by Christopher R. Schlieve (3179439)

    Published 2016
    “…(C) Significant increase in Bmi1 and Atoh1 expression and decrease in EphB2 expression was observed in doxycycline-treated VEGF OU compared to controls at 5 days (*p<0.05). …”
  19. 15879
  20. 15880